domperidone and Arrhythmia studies

Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.

Research Excerpts

Excerpt	Relevance	Reference
"We systematically searched MEDLINE, PubMed, EMBASE, Scopus and CINAHL Plus to identify observational studies examining the association of domperidone and sudden cardiac death and/or ventricular arrhythmia."	9.12	Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. ( Douros, A; Filion, KB; Moriello, C; Ou, LB, 2021)
"The first author performed EMBASE, PubMed and Scopus searches to identify human studies assessing the association between current domperidone exposure and cardiac arrhythmia or sudden death."	8.93	Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis. ( Holcombe, A; Leelakanok, N; Schweizer, ML, 2016)
" This study aimed to examine the risk of severe domperidone-induced ventricular arrhythmia (VA), compared to mosapride, itopride, or non-use of all three prokinetics, in the general population."	7.96	Risk of domperidone induced severe ventricular arrhythmia. ( Kim, K; Lee, H; Lee, YC; Min, YW; Rhee, PL; Son, HJ; Song, BG, 2020)
"The aim of this study is to examine the relationship between domperidone (commonly used off-label for lactation stimulation), ventricular arrhythmia and all-cause mortality during the postpartum period."	7.83	The association between domperidone and ventricular arrhythmia in the postpartum period. ( Hanley, GE; Mintzes, B; Morgan, SG; Oberlander, TF; Smolina, K, 2016)
"The results of two large epidemiological studies on the association between domperidone and ventricular arrhythmia or sudden cardiac death were published in 2015; one study was conducted in Taiwan and the other in the United Kingdom."	7.83	Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia. ( , 2016)
"Recent evidence suggested that oral form of domperidone may possess pro-arrhythmic effects and increase the risk of ventricular arrhythmia."	7.81	Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. ( Chen, HL; Hsiao, FY, 2015)
"Domperidone, a "hidden" neuroleptic, is used for symptomatic treatment of gastroesophageal reflux disease, despite its uncertain efficacy."	7.78	Domperidone: ventricular arrhythmia and sudden death (continued). ( , 2012)
"Domperidone is a prokinetic agent widely prescribed in adults and children with gastrointestinal disorders."	6.46	Domperidone and long QT syndrome. ( Giorgi, G; Rossi, M, 2010)
"Severe cardiac arrhythmias occurred in two patients."	5.27	Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. ( Hamer, J; Hunter, RW; Osborne, RJ; Slevin, ML, 1985)
"We systematically searched MEDLINE, PubMed, EMBASE, Scopus and CINAHL Plus to identify observational studies examining the association of domperidone and sudden cardiac death and/or ventricular arrhythmia."	5.12	Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. ( Douros, A; Filion, KB; Moriello, C; Ou, LB, 2021)
" From these publications, it cannot be concluded that domperidone exposure definitely increases the risk of "sudden cardiac death", "death associated with ventricular arrhythmia" or "ventricular arrhythmia" The most concrete result of these studies is that the risk is higher with metoclopramide exposure compared to domperidone exposure."	5.01	Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone. ( Tuğlular, I; Yüksel, K, 2019)
"The first author performed EMBASE, PubMed and Scopus searches to identify human studies assessing the association between current domperidone exposure and cardiac arrhythmia or sudden death."	4.93	Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis. ( Holcombe, A; Leelakanok, N; Schweizer, ML, 2016)
"To evaluate the risk of QT prolongation, ventricular arrhythmias and sudden cardiac death associated with the use of oral domperidone in adults without cancer."	4.91	[Cardiac adverse effects of domperidone in adult patients: a systematic review]. ( Avila, A; Caraballo, L; Marzi, M; Molina, G; Piskulic, L; Weitz, D, 2015)
" Reports of QT prolongation, ventricular arrhythmias and SCD were located (predominantly high/very high-dose IV domperidone)."	4.91	Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations. ( Buffery, PJ; Strother, RM, 2015)
" This study aimed to examine the risk of severe domperidone-induced ventricular arrhythmia (VA), compared to mosapride, itopride, or non-use of all three prokinetics, in the general population."	3.96	Risk of domperidone induced severe ventricular arrhythmia. ( Kim, K; Lee, H; Lee, YC; Min, YW; Rhee, PL; Son, HJ; Song, BG, 2020)
"Risk-minimization measures (RMM), including label revisions were implemented in Europe for domperidone because of evidence of increased incidence of cardiac arrhythmia and sudden cardiac death."	3.91	Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe. ( Fife, D; Hu, P; Kaplan, S; Oliveria, SA; Phillips, S; Richarz, U; Waller, J, 2019)
"Observational retrospective studies have linked domperidone and prolonged QT interval, ventricular arrhythmias and risk of sudden death."	3.85	[Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database]. ( Auffret, M; Béné, J; Gautier, S; Rochoy, M, 2017)
"The aim of this study is to examine the relationship between domperidone (commonly used off-label for lactation stimulation), ventricular arrhythmia and all-cause mortality during the postpartum period."	3.83	The association between domperidone and ventricular arrhythmia in the postpartum period. ( Hanley, GE; Mintzes, B; Morgan, SG; Oberlander, TF; Smolina, K, 2016)
"The results of two large epidemiological studies on the association between domperidone and ventricular arrhythmia or sudden cardiac death were published in 2015; one study was conducted in Taiwan and the other in the United Kingdom."	3.83	Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia. ( , 2016)
" In 2012, Health Canada released a warning regarding domperidone use, based on associations with life-threatening arrhythmias and death."	3.83	Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study. ( Al-Dabbagh, R; Cooray, M; Forbes, N; Liu, LW; Tse, F; Xenodemetropoulos, T; Yuan, Y, 2016)
"Recent evidence suggested that oral form of domperidone may possess pro-arrhythmic effects and increase the risk of ventricular arrhythmia."	3.81	Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. ( Chen, HL; Hsiao, FY, 2015)
"Domperidone, a "hidden" neuroleptic, is used for symptomatic treatment of gastroesophageal reflux disease, despite its uncertain efficacy."	3.78	Domperidone: ventricular arrhythmia and sudden death (continued). ( , 2012)
" In the second case, QT interval prolongation occurred in a patient taking quetiapine and citalopram, and whose use of hydrocholorothiazide and history of chronic alcohol abuse likely contributed by rendering the patient hypokalemic."	3.76	Multifactorial QT interval prolongation. ( Baranchuk, A; Digby, G; Machaalany, J; Malik, P; Methot, M; Redfearn, D; Simpson, CS, 2010)
"To determine whether oral domperidone is associated with QT interval prolongation and ventricular arrhythmia and to identify factors that can influence these effects."	3.74	Effect of domperidone on QT interval in neonates. ( Djeddi, D; Kongolo, G; Lefaix, C; Léké, A; Mounard, J, 2008)
"Several cases of QT prolongation and ventricular tachyarrhythmia have been reported with domperidone, a gastrokinetic and antiemetic agent available worldwide but still under investigation in the United States."	3.70	Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. ( Cardinal, R; Daleau, P; Drolet, B; Rousseau, G; Turgeon, J, 2000)
"The risk of sudden cardiac death (SCD) can be increased with the use of drugs."	3.01	Drug-induced Sudden Death: A Scoping Review. ( Amaro-Hosey, K; Blanco-Silvente, L; Capellà, D; Castells, X; Loma-Osorio, P, 2023)
"To assess the steady-state pharmacokinetic and QT(c) effects of domperidone and ketoconazole, given alone and together."	2.77	Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. ( Baisley, KJ; Boyce, MJ; Warrington, SJ, 2012)
"Domperidone is a proposed treatment of orthostatic hypotension (OH) in Parkinson's disease (PD)."	2.55	Domperidone for Hypotension in Parkinson's Disease: A Systematic Review. ( Bacchi, S; Chim, I; Kramer, P; Postuma, RB, 2017)
"Domperidone is a prokinetic agent widely prescribed in adults and children with gastrointestinal disorders."	2.46	Domperidone and long QT syndrome. ( Giorgi, G; Rossi, M, 2010)
"The risk of serious ventricular arrhythmias (SVA) in clinical practice in China has not been investigated."	1.56	Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China. ( Jiang, K; Liang, W; Qiu, H; Shu, M; Wu, K; Zhang, D; Zhang, Y, 2020)
"The phenomenon of sudden cardiac death is usually related to the worsening of existing heart conditions leading to ventricular arrhythmia (VA)."	1.42	A case of sudden cardiac death following Domperidone self-medication. ( De Leo, D; Fais, P; Gottardo, R; Laposata, C; Lockwood, R; Vermiglio, E, 2015)
"There have been reports of cardiac arrest in older patients associated with domperidone."	1.27	Continuous ECG monitoring of children with cancer receiving domperidone. ( Campbell, RW; Craft, AW; Hunter, AS; Nobbs, J; Pritchard-Jones, K; Ratcliffe, JM, 1986)
"Severe cardiac arrhythmias occurred in two patients."	1.27	Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. ( Hamer, J; Hunter, RW; Osborne, RJ; Slevin, ML, 1985)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (11.11)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (11.11)	29.6817
2010's	24 (66.67)	24.3611
2020's	4 (11.11)	2.80

Trial			Phase	Enrollment	Study Type	Start Date	Status
Randomized Clinical Trial: Use of Domperidone to Increase Milk Production in Mothers With Newborns Hospitalized in Neonatology[NCT03221855]			Early Phase 1	30 participants (Actual)	Interventional	2013-03-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Drug-induced Sudden Death: A Scoping Review. Current drug safety, 2023, Volume: 18, Issue:3 Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Humans; Risk Factor	2023
Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta-analysis of observational studies. British journal of clinical pharmacology, 2021, Volume: 87, Issue:10 Topics: Antiemetics; Arrhythmias, Cardiac; Cross-Over Studies; Death, Sudden, Cardiac; Domperidone; Humans;	2021
Domperidone for Hypotension in Parkinson's Disease: A Systematic Review. Journal of Parkinson's disease, 2017, Volume: 7, Issue:4 Topics: Animals; Arrhythmias, Cardiac; Databases, Bibliographic; Death, Sudden, Cardiac; Domperidone; Dopami	2017
Critical review of European Medicines Agency (EMA) assessment report and related literature on domperidone. International journal of clinical pharmacy, 2019, Volume: 41, Issue:2 Topics: Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Humans; Metoclopramide; Risk	2019
[Proarrhythmic effects of domperidone in infants: a systematic review]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2014, Sep-16, Volume: 38, Issue:5 Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Cisapride; Contraindications; Cytochrome P-450 CYP3A; Dom	2014
[Cardiac adverse effects of domperidone in adult patients: a systematic review]. Revista medica de Chile, 2015, Volume: 143, Issue:1 Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Gastroesophag	2015
Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations. The New Zealand medical journal, 2015, Jun-12, Volume: 128, Issue:1416 Topics: Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Death, Sudde	2015
Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis. Clinical drug investigation, 2016, Volume: 36, Issue:2 Topics: Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Case-Control	2016
Domperidone and long QT syndrome. Current drug safety, 2010, Jul-02, Volume: 5, Issue:3 Topics: Adult; Animals; Arrhythmias, Cardiac; Child; Death, Sudden, Cardiac; Domperidone; Dopamine Antagonis	2010

Article	Year
Risk of Serious Ventricular Arrhythmia in Users of Gastrointestinal Medications: A Retrospective Cohort Study in China. Advances in therapy, 2020, Volume: 37, Issue:4 Topics: Administration, Oral; Adult; Antiemetics; Arrhythmias, Cardiac; China; Databases, Factual; Domperido	2020
Risk of domperidone induced severe ventricular arrhythmia. Scientific reports, 2020, 07-22, Volume: 10, Issue:1 Topics: Adolescent; Adult; Aged; Antiemetics; Arrhythmias, Cardiac; Benzamides; Benzyl Compounds; Child; Chi	2020
Additive Proarrhythmic Effect of Combined Treatment with QT-Prolonging Agents. Cardiovascular toxicology, 2018, Volume: 18, Issue:1 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Domperidone; Drug Interactions; Erythromycin; Fema	2018
Use of domperidone and risk of ventricular arrhythmia in the postpartum period: getting to the heart of the matter. Pharmacoepidemiology and drug safety, 2017, Volume: 26, Issue:7 Topics: Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Humans; Postpartum Period	2017
Response to "use of domperidone and risk of ventricular arrhythmia in the postpartum period: Getting to the heart of the matter". Pharmacoepidemiology and drug safety, 2017, Volume: 26, Issue:7 Topics: Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Humans; Postpartum Period	2017
Metoclopramide, domperidone: sudden cardiac death, ventricular arrhythmia. Prescrire international, 2016, Volume: 25, Issue:175 Topics: Antiemetics; Arrhythmias, Cardiac; Clinical Decision-Making; Death, Sudden, Cardiac; Domperidone; Do	2016
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe. Clinical drug investigation, 2019, Volume: 39, Issue:11 Topics: Adult; Antiemetics; Arrhythmias, Cardiac; Cardiac Conduction System Disease; Cross-Sectional Studies	2019
Pharmacological management of low milk supply with domperidone: separating fact from fiction. The Medical journal of Australia, 2014, Sep-01, Volume: 201, Issue:5 Topics: Age Factors; Arrhythmias, Cardiac; Breast Feeding; Death, Sudden, Cardiac; Domperidone; Dopamine Ant	2014
Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study. Pharmacoepidemiology and drug safety, 2015, Volume: 24, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Co	2015
A case of sudden cardiac death following Domperidone self-medication. Forensic science international, 2015, Volume: 254 Topics: Alcoholism; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperidone; Female; Gastrointestinal Agen	2015
The association between domperidone and ventricular arrhythmia in the postpartum period. Pharmacoepidemiology and drug safety, 2016, Volume: 25, Issue:10 Topics: Adult; Arrhythmias, Cardiac; British Columbia; Cohort Studies; Domperidone; Dopamine Antagonists; Fe	2016
Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a "Black Box" Warning: A Canadian Tertiary Care Center Study. Canadian journal of gastroenterology & hepatology, 2016, Volume: 2016 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Domperido	2016
[Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database]. Revue d'epidemiologie et de sante publique, 2017, Volume: 65, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Arrhythmias, Cardiac; Brugada Syndrome; Car	2017
Severe Proarrhythmic Potential of the Antiemetic Agents Ondansetron and Domperidone. Cardiovascular toxicology, 2017, Volume: 17, Issue:4 Topics: Animals; Antiemetics; Arrhythmias, Cardiac; Domperidone; Dose-Response Relationship, Drug; Female; O	2017
Domperidone and sudden death. Cardiac rhythm disorders: QT interval prolongation. Prescrire international, 2008, Volume: 17, Issue:94 Topics: Antiemetics; Arrhythmias, Cardiac; Canada; Death, Sudden, Cardiac; Domperidone; Humans; Long QT Synd	2008
Effect of domperidone on QT interval in neonates. The Journal of pediatrics, 2008, Volume: 153, Issue:5 Topics: Administration, Oral; Arrhythmias, Cardiac; Domperidone; Dopamine Antagonists; Drug-Related Side Eff	2008
Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in EPIC's General Practice Research Database. Pharmacoepidemiology and drug safety, 2008, Volume: 17, Issue:12 Topics: Arrhythmias, Cardiac; Cisapride; Cohort Studies; Databases, Factual; Death, Sudden, Cardiac; Domperi	2008
Multifactorial QT interval prolongation. Cardiology journal, 2010, Volume: 17, Issue:2 Topics: Alcoholism; Amiodarone; Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers; Citalopram; Cyclohex	2010
Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiology and drug safety, 2010, Volume: 19, Issue:9 Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Contro	2010
Domperidone: ventricular arrhythmia and sudden death (continued). Prescrire international, 2012, Volume: 21, Issue:129 Topics: Aged; Antipsychotic Agents; Arrhythmias, Cardiac; Death, Sudden; Domperidone; Female; Gastroesophage	2012
Health Canada advisory on domperidone should I avoid prescribing domperidone to women to increase milk production [corrected]? Canadian family physician Medecin de famille canadien, 2012, Volume: 58, Issue:9 Topics: Arrhythmias, Cardiac; Canada; Death, Sudden, Cardiac; Domperidone; Female; Galactogogues; Humans; La	2012
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation, 2000, Oct-17, Volume: 102, Issue:16 Topics: Action Potentials; Animals; Antiemetics; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cation Tr	2000
Cardiotoxicity of intravenous domperidone. Lancet (London, England), 1985, Aug-17, Volume: 2, Issue:8451 Topics: Arrhythmias, Cardiac; Domperidone; Female; Humans; Infusions, Parenteral; Vomiting	1985
Cardiotoxicity of domperidone. Lancet (London, England), 1985, Sep-28, Volume: 2, Issue:8457 Topics: Aged; Arrhythmias, Cardiac; Domperidone; Heart; Humans; Male	1985
Continuous ECG monitoring of children with cancer receiving domperidone. Pediatric hematology and oncology, 1986, Volume: 3, Issue:4 Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Child	1986
Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone. Human toxicology, 1985, Volume: 4, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Cisplat	1985

domperidone and Arrhythmia

Research Excerpts

Research

Studies (36)

Authors

Clinical Trials (1)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Amaro-Hosey, K	1
Castells, X	1
Blanco-Silvente, L	1
Loma-Osorio, P	1
Capellà, D	1
Zhang, Y	1
Shu, M	1
Liang, W	1
Jiang, K	1
Zhang, D	1
Qiu, H	1
Wu, K	1
Song, BG	1
Lee, YC	1
Min, YW	1
Kim, K	1
Lee, H	1
Son, HJ	1
Rhee, PL	1
Ou, LB	1
Moriello, C	1
Douros, A	1
Filion, KB	1
Frommeyer, G	2
Fischer, C	2
Ellermann, C	2
Dechering, DG	2
Kochhäuser, S	2
Lange, PS	2
Wasmer, K	1
Fehr, M	2
Eckardt, L	2
Grzeskowiak, LE	2
Smithers, LG	1
Smolina, K	2
Morgan, S	1
Mintzes, B	2
Hanley, G	1
Oberlander, T	1
Bacchi, S	1
Chim, I	1
Kramer, P	1
Postuma, RB	1
Yüksel, K	1
Tuğlular, I	1
Fife, D	2
Waller, J	1
Kaplan, S	1
Hu, P	1
Phillips, S	1
Oliveria, SA	1
Richarz, U	1
Amir, LH	1
Caraballo, L	2
Molina, G	2
Weitz, D	2
Piskulic, L	2
Avila, A	2
Marzi, M	2
Chen, HL	1
Hsiao, FY	1
Buffery, PJ	1
Strother, RM	1
Fais, P	1
Vermiglio, E	1
Laposata, C	1
Lockwood, R	1
Gottardo, R	1
De Leo, D	1
Leelakanok, N	1
Holcombe, A	1
Schweizer, ML	1
Hanley, GE	1
Oberlander, TF	1
Morgan, SG	1
Forbes, N	1
Cooray, M	1
Al-Dabbagh, R	1
Yuan, Y	1
Tse, F	1
Liu, LW	1
Xenodemetropoulos, T	1
Rochoy, M	1
Auffret, M	1
Béné, J	1
Gautier, S	1
Djeddi, D	1
Kongolo, G	1
Lefaix, C	1
Mounard, J	1
Léké, A	1
Hennessy, S	1
Leonard, CE	1
Palumbo, CM	1
Bilker, WB	1
Newcomb, C	1
Kimmel, SE	1
Rossi, M	1
Giorgi, G	1
Digby, G	1
Machaalany, J	1
Malik, P	1
Methot, M	1
Simpson, CS	1
Redfearn, D	1
Baranchuk, A	1
Johannes, CB	1
Varas-Lorenzo, C	1
McQuay, LJ	1
Midkiff, KD	1
Boyce, MJ	1
Baisley, KJ	1
Warrington, SJ	1
Bozzo, P	1
Koren, G	1
Ito, S	1
Drolet, B	1
Rousseau, G	1
Daleau, P	1
Cardinal, R	1
Turgeon, J	1
Osborne, RJ	2
Slevin, ML	2
Hunter, RW	2
Hamer, J	2
Quinn, N	1
Parkes, D	1
Jackson, G	1
Upward, J	1
Ratcliffe, JM	1
Nobbs, J	1
Campbell, RW	1
Hunter, AS	1
Pritchard-Jones, K	1
Craft, AW	1